CTS-2090

N/A

Report date: 2023/07/21 11:35:50
NME

Base Information

Drug NameCTS-2090
Drug Alias NameCTS-2090
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInflammasomes inhibitorsCaspase-1 inhibitors
TargetsCaspase-1Inflammasomes
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesConatus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHistogen Inc
Inactive CompaniesConatus Pharmaceuticals Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A